Pinion Investment Advisors’s AbbVie ABBV Stock Holding History

Pinion Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.01M	Buy	4,016 +56	+1%	+$12K	0.19%	78
2026 Q1	$861K	Sell	3,960 -773	-16%	-$171K	0.2%	81
2025 Q4	$1.08M	Sell	4,733 -451	-9%	-$103K	0.26%	58
2025 Q3	$1.18M	Buy	5,184 +321	+7%	+$65.4K	0.32%	52
2025 Q2	$903K	Buy	4,863 +167	+4%	+$31K	0.31%	61
2025 Q1	$984K	Buy	4,696 +490	+12%	+$95.3K	0.22%	70
2024 Q4	$747K	Buy	4,206 +143	+4%	+$26.3K	0.3%	63
2024 Q3	$802K	Buy	4,063 +405	+11%	+$75.6K	0.34%	61
2024 Q2	$627K	Sell	3,658 -389	-10%	-$64.4K	0.31%	62
2024 Q1	$737K	Buy	4,047 +784	+24%	+$135K	0.38%	49
2023 Q4	$506K	Buy	+3,263	New	+$476K	0.3%	74

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Pinion Investment Advisors's ABBV Position: Q2 2026 in Review

Pinion Investment Advisors increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $12K and bringing the position to 4,016 shares worth $1.01M. The position accounts for 0.19% of the portfolio, ranked #78.

Pinion Investment Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.18M in Q3 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Pinion Investment Advisors held 4,016 shares of AbbVie worth $1.01M as of Q2 2026.
Pinion Investment Advisors bought 56 AbbVie shares in Q2 2026, an estimated $12K.
AbbVie made up 0.19% of Pinion Investment Advisors's portfolio in Q2 2026, its #78 holding.
Pinion Investment Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
Pinion Investment Advisors's AbbVie position peaked at $1.18M in Q3 2025.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pinion Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.